Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 279 | 3 | ANGIOGENESIS//LYMPHANGIOGENESIS//VEGF | 43269 |
| 379 | 2 | LYMPHANGIOGENESIS//ANGIOGENESIS//VEGF | 17562 |
| 14959 | 1 | BEVACIZUMAB//OVARIAN CANCER//GYNECOL ONCOL | 766 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | BEVACIZUMAB | authKW | 377028 | 26% | 5% | 196 |
| 2 | OVARIAN CANCER | authKW | 328961 | 41% | 3% | 315 |
| 3 | GYNECOL ONCOL | address | 91968 | 21% | 1% | 162 |
| 4 | RECURRENT OVARIAN CANCER | authKW | 91306 | 3% | 10% | 22 |
| 5 | CLIN MED GYNECOL PATHOL FORENS MED | address | 82287 | 0% | 100% | 2 |
| 6 | GYNECOL MED ONCOL EXPT THER EUT | address | 82287 | 0% | 100% | 2 |
| 7 | HLTH HOSP CLIN | address | 82287 | 0% | 100% | 2 |
| 8 | TREBANANIB | authKW | 77947 | 1% | 32% | 6 |
| 9 | CLIN MED GYNAECOL PATHOL FORENS MED | address | 74055 | 0% | 60% | 3 |
| 10 | EPITHELIAL OVARIAN CANCER | authKW | 62618 | 5% | 4% | 40 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 16585 | 75% | 0% | 575 |
| 2 | Obstetrics & Gynecology | 6190 | 27% | 0% | 210 |
| 3 | Pharmacology & Pharmacy | 110 | 10% | 0% | 73 |
| 4 | Pathology | 59 | 3% | 0% | 24 |
| 5 | Medicine, Research & Experimental | 35 | 4% | 0% | 29 |
| 6 | Hematology | 8 | 2% | 0% | 14 |
| 7 | Biotechnology & Applied Microbiology | 4 | 3% | 0% | 20 |
| 8 | Reproductive Biology | 3 | 1% | 0% | 6 |
| 9 | Surgery | 1 | 3% | 0% | 25 |
| 10 | Medical Laboratory Technology | 0 | 0% | 0% | 3 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | GYNECOL ONCOL | 91968 | 21% | 1% | 162 |
| 2 | CLIN MED GYNECOL PATHOL FORENS MED | 82287 | 0% | 100% | 2 |
| 3 | GYNECOL MED ONCOL EXPT THER EUT | 82287 | 0% | 100% | 2 |
| 4 | HLTH HOSP CLIN | 82287 | 0% | 100% | 2 |
| 5 | CLIN MED GYNAECOL PATHOL FORENS MED | 74055 | 0% | 60% | 3 |
| 6 | BGOG | 54856 | 0% | 67% | 2 |
| 7 | GLOBAL DEV ONCOL | 54856 | 0% | 67% | 2 |
| 8 | HAEMATOL BLOOD BANKING | 54856 | 0% | 67% | 2 |
| 9 | NHS ONCOL | 54856 | 0% | 67% | 2 |
| 10 | UMR 37 38 | 54856 | 0% | 67% | 2 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | GYNECOLOGIC ONCOLOGY | 49747 | 15% | 1% | 118 |
| 2 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 13557 | 5% | 1% | 39 |
| 3 | JOURNAL OF GYNECOLOGIC ONCOLOGY | 2524 | 1% | 1% | 5 |
| 4 | CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2289 | 1% | 1% | 11 |
| 5 | EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY | 2260 | 2% | 0% | 13 |
| 6 | EXPERT OPINION ON INVESTIGATIONAL DRUGS | 2220 | 1% | 0% | 11 |
| 7 | LANCET ONCOLOGY | 2084 | 1% | 1% | 10 |
| 8 | JOURNAL OF OVARIAN RESEARCH | 1860 | 1% | 1% | 5 |
| 9 | ONCOTARGETS AND THERAPY | 1844 | 1% | 0% | 10 |
| 10 | JOURNAL OF CLINICAL ONCOLOGY | 1654 | 3% | 0% | 26 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |